Selection of Recent Oncology Articles Published in The Lancet

On this page, you will find links to the latest oncology-related research articles published in The Lancet.

Filter

Date Title Topic
10 Dec 2018 Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised , placebo-controlled phase 3... Plasma Cell Dyscrasias
15 Nov 2018 De-intensified treatment in human papillomavirus-positive oropharyngeal cancer Head and Neck Cancers
26 Oct 2018 Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Prostate Cancer
07 Jul 2018 Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-i... Urothelial Cancers , Surgical Oncology
09 Jun 2018 Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-la... Anticancer Agents , Gastric Cancer , Therapy , Biological Therapy
15 May 2018 Immunoscore for (colorectal) cancer precision medicine. Colon and Rectal Cancer , Personalised/Precision Medicine , Basic Principles in the Management and Treatment (of cancer)
13 Feb 2018 Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority tr... Immunotherapy , Hepatobiliary Cancers , Therapy
06 Feb 2018 Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of... Aetiology, Epidemiology, Screening and Prevention , Basic Scientific Principles
23 Dec 2017 Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre,... Immunotherapy , Urothelial Cancers , Therapy
21 Oct 2017 Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNO... Immunotherapy , Skin Cancers , Melanoma , Therapy
20 Oct 2017 PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 t... Haematological Malignancies , Lymphomas , Staging Procedures (clinical staging) , Basic Principles in the Management and Treatment (of cancer) , Imaging
05 Oct 2017 Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemothera... Immunotherapy , Gastrointestinal Cancers , Gastric Cancer , Therapy
12 Sep 2017 Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based... Immunotherapy , Genitourinary Cancers , Urothelial Cancers , Therapy
12 Sep 2017 Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-co... Immunotherapy , Gynaecological Malignancies , Ovarian Cancer , Therapy
09 Sep 2017 CAR T-cells: an exciting frontier in cancer therapy. Immunotherapy , Translational Research , Basic Principles in the Management and Treatment (of cancer) , Therapy